Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,142 across all filing types
Latest filing 2008-06-19 Capital/Financing Update
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
PROSPECTUS SUPPLEMENT
Capital/Financing Update Classification · 100% confidence The document is a Prospectus Supplement filed pursuant to Rule 424(b)(5) under the Securities Act of 1933. It details the offering of debt securities (notes) by Johnson & Johnson, including terms, interest rates, redemption options, underwriting details, and use of proceeds. The document is a formal disclosure related to a capital raising transaction, specifically a debt offering. It is not an annual or quarterly report, audit report, earnings release, or any other type of financial report. It is a detailed disclosure about a financing activity. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and content confirm it is the actual offering document, not just an announcement or a brief summary.
2008-06-19 English
FWP
Capital/Financing Update Classification · 100% confidence The document is a Pricing Term Sheet for Johnson & Johnson's 5.15% Senior Unsecured Notes due 2018. It includes details about the bond issuance such as coupon rate, maturity date, size, yield, ratings, and underwriters. The document is filed pursuant to Rule 433, which relates to free writing prospectuses used in securities offerings. This is a capital markets document providing information about a financing activity, specifically a debt issuance. It is not a full financial report, earnings release, or regulatory filing unrelated to financing. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is short and focused on the financing terms, consistent with CAP filings.
2008-06-19 English
FWP
Capital/Financing Update Classification · 100% confidence The document is a Pricing Term Sheet for a debt offering by Johnson & Johnson, detailing terms of 5.85% Senior Unsecured Notes due 2038. It includes information on coupon, maturity, size, ratings, and underwriters. This is a capital markets document related to a financing activity, specifically a debt issuance. It is not a full financial report, earnings release, or regulatory filing. The document is a direct update on a financing transaction, fitting the Capital/Financing Update category.
2008-06-19 English
PROSPECTUS SUPPLEMENT
Capital/Financing Update Classification · 100% confidence The document is a Preliminary Prospectus Supplement filed pursuant to Rule 424(B)(3) related to a securities offering by Johnson & Johnson. It includes detailed information about the terms of notes being offered, redemption provisions, underwriting details, and references to registration statements and SEC filings. The document is clearly a capital markets filing related to fundraising and issuance of debt securities. It is not an annual or quarterly report, audit report, management or board announcement, earnings release, nor a proxy or voting document. The presence of underwriting details, redemption terms, and registration statement references confirms it is a Capital/Financing Update.
2008-06-18 English
PRIMARY DOCUMENT
Director's Dealing
2008-06-11 English
PRIMARY DOCUMENT
Director's Dealing
2008-06-11 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.